Scantlebery, A. M. L., Uil, M., Butter, L. M., Poelman, R., Claessen, N., Girardin, S. E., . . . Leemans, J. C. (2019). NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin. PloS one, 14(3), e0214437. https://doi.org/10.1371/journal.pone.0214437
Citácia podle Chicago (17th ed.)Scantlebery, Angelique M. L., Melissa Uil, Loes M. Butter, Renée Poelman, Nike Claessen, Stephen E. Girardin, Sandrine Florquin, Joris J. T. H. Roelofs, a Jaklien C. Leemans. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced by Multiple Low Doses of Streptozotocin." PloS One 14, no. 3 (2019): e0214437. https://doi.org/10.1371/journal.pone.0214437.
Citácia podľa MLA (8th ed.)Scantlebery, Angelique M. L., et al. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced by Multiple Low Doses of Streptozotocin." PloS One, vol. 14, no. 3, 2019, p. e0214437, https://doi.org/10.1371/journal.pone.0214437.